𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trials with toremifene in advanced breast cancer: A review

✍ Scribed by Ritva Valavaara

Publisher
Springer US
Year
1990
Tongue
English
Weight
334 KB
Volume
16
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recombinant gamma interferon in advanced
Recombinant gamma interferon in advanced breast cancer: A phase II trial
✍ Hyman B. Muss; Mary Caponera; Patricia J. Zekan; Don V. Jackson; John J. Stuart; πŸ“‚ Article πŸ“… 1986 πŸ› Springer US 🌐 English βš– 365 KB

Fifteen patients with advanced carcinoma of the breast who had failed prior chemotherapy, were treated with recombinant gamma interferon at a dose of 2mg/m2 (1mg = 2.4 X 10(7) international units) intravenously for five consecutive days every other week. The median patient age was 51 and all patient

Phase II trial of fludarabine phosphate
Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer
✍ A. Mittelman; R. Ashikari; T. Ahmed; S. Savona; P. Arnold; Z. Arlin πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 181 KB

Eighteen patients with advanced breast cancer were entered into a phase II study of fludarabine phosphate. Fludarabine phosphate was given by continuous infusion for 5 days, at a starting dose of 20 mg/m2 per day for patients previously treated with two or more regimens and 25 mg/m2 per day for mini